Genetic Subtypes of IGHD (Types IA, IB, II, III)

Once a child is diagnosed with Isolated Growth Hormone Deficiency (IGHD), doctors often look at the underlying genetic cause to understand how the condition will behave. There are four primary genetic subtypes—Types IA, IB, II, and III—each with its own inheritance pattern and clinical characteristics ^[1][2].

The Four Genetic Subtypes

The subtypes are defined by how they are passed down through families and the specific gene involved.

Understanding Inheritance Terms

• Autosomal Recessive: Both parents must carry a copy of the mutated gene, though the parents themselves are usually of normal height ^[1].
• Autosomal Dominant: Only one parent needs to pass on the gene. In these cases, the parent who carries the gene may also be shorter than average ^[3].
• X-Linked: The gene is located on the X chromosome. This type typically affects males and is passed down from the mother’s side ^[4].

Deep Dive: Type IA and the Immune Challenge

Type IA is the most severe form of IGHD because the GH1 gene is completely missing or non-functional ^[1]. From birth, the body produces zero growth hormone. This complete absence creates a unique medical challenge called immunological naivety ^[5].

Because the child’s body has never “seen” a growth hormone molecule, it may view the treatment (recombinant human growth hormone) as a foreign invader ^[5][1]. This can cause the child’s immune system to create anti-GH antibodies ^[6].

• What this means for treatment: These antibodies can “neutralize” the medication, making it stop working. If this happens, a child who was growing well might suddenly stop growing—a phenomenon called growth arrest or secondary growth failure ^[1][7].
• The alternative path: If a child with Type IA develops high levels of these antibodies and stops responding to standard therapy, doctors may switch them to IGF-1 therapy, which bypasses the need for growth hormone entirely to promote growth ^[7][8].

Types IB, II, and III: Milder but Variable

• Type IB: This is the most common genetic form. These children have low but detectable levels of growth hormone ^[1]. They generally respond very well to treatment and rarely develop the neutralizing antibodies seen in Type IA ^[1].
• Type II: This type is unique because it is “dominant.” It is often caused by a “clog” in the pituitary gland’s machinery, where an abnormal hormone variant prevents the healthy hormone from being released ^[3][9]. The onset of growth failure can be more gradual than in Type IA ^[10].
• Type III: This form is linked to the X chromosome and sometimes involves other symptoms, such as intellectual disability or structural changes in the brain’s midline ^[4][11]. Historically, some cases were linked to immune deficiencies (like low immunoglobulin levels), though this is not present in all Type III cases ^[12].

Knowing your child’s specific subtype allows your medical team to tailor their monitoring—checking growth more frequently or watching for immune system signals—to ensure the best possible outcome.